http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101642637-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0658 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34 |
| filingDate | 2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101642637-B1 |
| titleOfInvention | A method for differentiation of tonsil-derived mesenchymal stem cell into muscle cells |
| abstract | The present invention relates to a method for differentiating myoblasts and muscle cells from mesenchymal stem cells, and a cell therapy agent using the same. The differentiation method of the present invention shows high ability to differentiate into myocytes and muscle cells, and it is possible to secure a large amount of myosomes and muscle cells. The cells differentiated according to the present invention are highly tissue-compatible by using an abandoned autologous tissue, It shows good availability as a therapeutic agent. |
| priorityDate | 2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 382.